Lupin launches Ortho-Cyclen tablets in US
New Delhi : Drug major Lupin has launched generic version of contraceptives Ortho-Cyclen tablets after approval from the US health regulator.
In a BSE filing, Lupin said, "It has launched its Norgestimate and Ethinyl Estradiol tablets USP, 0.25 mg/0.035 mg having received approval from the United States Food and Drug Administration (FDA) earlier to market a generic version of Janssen Pharmaceuticals Inc's Ortho-Cyclen 28 tablets".
Lupin's Norgestimate and Ethinyl Estradiol tablets USP, 0.25 mg/0.035 mg are the AB rated generic equivalent of Janssen Pharmaceuticals Inc's Ortho-Cyclen 28 tablets (Norgestimate/Ethinyl Estradiol).
Quoting IMS MAT September 2016 data, Lupin said, Ortho-Cyclen 28 tablets had the US sales of USD 204 million.
Shares of Lupin were trading 0.81 per cent higher at Rs 1,494.50 apiece on BSE.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd